Baird Medical Investment Stock (NASDAQ:BDMD)


RevenueFinancialsChart

Previous Close

$7.17

52W Range

$1.05 - $13.52

50D Avg

$3.80

200D Avg

$8.16

Market Cap

$258.08M

Avg Vol (3M)

$2.12M

Beta

0.14

Div Yield

-

BDMD Company Profile


Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

Show More

Industry

Healthcare

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

148

IPO Date

Dec 16, 2021

Website

BDMD Performance


BDMD Financial Summary


Dec 23Dec 22Dec 21
Revenue$31.46M$35.09M$27.72M
Operating Income$11.86M$13.63M$11.92M
Net Income$10.55M$12.57M$11.68M
EBITDA$12.85M$14.49M$15.41M
Basic EPS-$0.50$0.40
Diluted EPS-$0.50$0.40

Fiscal year ends in Dec 23 | Currency in USD